Latest News of PHAR
AFT Pharmaceuticals (NZSE:AFT) shareholders have endured a 34% loss from investing in the stock three years ago
By Yahoo! Finance | 11 months ago
More Big Pharma/Big Government Attacks Coming - Arepanrix: Package Insert & Approval Letter Pt 2
By The Washington Standard | 11 months ago
Here's Why Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Is Among the Best Diabetes Stocks to Buy Under $10
By Yahoo! Finance | 11 months ago
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation
By Yahoo! Finance | 11 months ago
Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A banker
By Business Insider | 11 months ago
Rhythm Pharmaceuticals Shows Market Leadership With Jump To 91 RS Rating
By Investor's Business Daily | 11 months ago
UK Approves Merck's Hypertension Drug Acquired Via $11 Billion Acceleron Pharma Deal
By Yahoo! Finance | 11 months ago
'Pharma Bro' Martin Shkreli Predicts Liquidation Doom For MicroStrategy Amid Fall Below $300, Says Bitcoin Will Hit $250K Without Michael Saylor
By Yahoo! Finance | 11 months ago
Aspen Pharmacare Holdings (JSE:APN) sheds 4.2% this week, as yearly returns fall more in line with earnings growth
By Yahoo! Finance | 11 months ago
Veru Sells FC2 Condom Business For $18 Million, Focuses On Biopharma Pipeline
By Yahoo! Finance | 11 months ago
Shareholders in Arrowhead Pharmaceuticals (NASDAQ:ARWR) have lost 66%, as stock drops 9.3% this past week
By Yahoo! Finance | 1 year ago
Lantern Pharma Inc. (LTRN) Receives Second FDA Fast Track Designation for LP-184 in Triple Negative Breast Cancer
By Yahoo! Finance | 1 year ago